CellResearch Corporation
Singapore
About CellResearch Corporation
CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. It’s original remit was to provide skin and scar cells to laboratories around the world for research, as well as to perform contract research for cell laboratories internationally. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we are due shortly to start USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing. To maximise future Cord Lining Stem Cell use, CellResearch Corporation feels that the membrane from which the cells are derived should be stored. Today we license our proprietary technology to partners who bank Cord Lining Membrane in various territories around the world. Our extensive experience with Cord Lining Stem Cells has taught us much, and we have been able to utilise this knowledge to produce a ground breaking cosmeceutical line called CALECIM® which has been observed to improve the skin appearance after topical application.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Last round: Series Unknown (Feb 2016)
- Website: cellresearchcorp.com
- Phone: +656-444-9968
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cellresearch-corporation-172744 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.